M D Adelson

Author PubWeight™ 16.11‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the Gynecologic Oncology Group. J Clin Oncol 1999 1.66
2 Structural and functional integrity of ovarian tumor tissue obtained by ultrasonic aspiration. Cancer 1991 1.40
3 Evaluation of the polymerase chain reaction for the detection of human papillomavirus from urine. J Med Virol 1995 0.95
4 Granulocytic sarcoma of the uterine cervix--literature review of granulocytic sarcoma of the female genital tract. Gynecol Oncol 1992 0.89
5 Lupron retards proliferation of ovarian epithelial tumor cells cultured in serum-free medium. J Clin Endocrinol Metab 1991 0.86
6 Randomized placebo-controlled multicenter evaluation of diethyldithiocarbamate for chemoprotection against cisplatin-induced toxicities. J Clin Oncol 1995 0.85
7 Intraperitoneal interferon-alpha in residual ovarian carcinoma: a phase II gynecologic oncology group study. Gynecol Oncol 1999 0.84
8 Erythrocytosis associated with a placental-site trophoblastic tumor. Obstet Gynecol 1992 0.82
9 A phase II trial of vincristine in advanced or recurrent endometrial carcinoma. A Gynecologic Oncology Group Study. Am J Clin Oncol 1993 0.82
10 Brachial plexus neuropathies after advanced laparoscopic surgery. Fertil Steril 1993 0.82
11 Aging and development of ovarian epithelial carcinoma: the relevance of changes in ovarian stromal androgen production. Adv Exp Med Biol 1993 0.81
12 Evaluation of two commercially available nucleic acid hybridization assays for the detection and typing of human papillomavirus in clinical specimens. Am J Clin Pathol 1991 0.81
13 Echinomycin (NSC 526417) in advanced ovarian cancer. A phase II trial of the Gynecologic Oncology Group. Am J Clin Oncol 1990 0.79
14 Quantitative evaluation of the skin and accessory appendages in vulvar carcinoma in situ. Obstet Gynecol 1989 0.78
15 Aromatization of testosterone by epithelial tumor cells cultured from patients with ovarian carcinoma. Cancer Res 1988 0.78
16 Cervical carcinoma DNA content, S-fraction, and malignancy grading. I. Interrelationships. Gynecol Oncol 1987 0.76
17 A phase II trial of gallium nitrate (NSC #15200) in previously treated ovarian carcinoma. A Gynecologic Oncology Group Study. Am J Clin Oncol 1991 0.75
18 Emergence of imipenem-resistant Pseudomonas aeruginosa during treatment of intra-abdominal infection in a patient with ovarian carcinoma. J Natl Med Assoc 1988 0.75
19 Ultrasonic surgical aspiration in the treatment of vulvar disease. Obstet Gynecol 1991 0.75
20 Cervical carcinoma DNA content, S-fraction, and malignancy grading. II. Comparison with clinical staging. Gynecol Oncol 1987 0.75
21 Phase II trial of vinblastine in advanced ovarian carcinoma. A Gynecologic Oncology Group study. Invest New Drugs 1990 0.75
22 Appraising a clinical journal article in obstetrics and gynecology. Am J Obstet Gynecol 1989 0.75
23 Herpes simplex and human papillomavirus genital infections: controversy over obstetric management. Clin Obstet Gynecol 1990 0.75
24 A phase II trial of merbarone (NSC 336628) in the treatment of recurrent epithelial ovarian carcinoma. A Gynecologic Oncology Group Study. Am J Clin Oncol 1996 0.75
25 Combined tubal and molar pregnancy: case report. Am J Obstet Gynecol 1988 0.75
26 Endometrial adenocarcinoma without prior hormone replacement in a diabetic patient with gonadal dysgenesis. Obstet Gynecol 1992 0.75
27 Palliative radiotherapy for ovarian cancer. Int J Radiat Oncol Biol Phys 1987 0.75